1 Scope of the Report 1.1 Market Introduction 1.2 Years Considered 1.3 Research Objectives 1.4 Market Research Methodology 1.5 Research Process and Data Source 1.6 Economic Indicators 1.7 Currency Considered 2 Executive Summary 2.1 World Market Overview 2.1.1 Global Neurological Biomarkers Consumption 2016-2026 2.1.2 Neurological Biomarkers Consumption CAGR by Region 2.2 Neurological Biomarkers Segment by Type 2.2.1 Proteomics 2.2.2 Genomics 2.2.3 Imaging 2.2.4 Bioinformatics 2.2.5 Others 2.3 Neurological Biomarkers Sales by Type 2.3.1 Global Neurological Biomarkers Sales Market Share by Type (2016-2021) 2.3.2 Global Neurological Biomarkers Revenue and Market Share by Type (2016-2021) 2.3.3 Global Neurological Biomarkers Sale Price by Type (2016-2021) 2.4 Neurological Biomarkers Segment by Application 2.4.1 Diagnostics 2.4.2 Drug Discovery 2.4.3 Personalized Medicine 2.4.4 Others 2.5 Neurological Biomarkers Sales by Application 2.5.1 Global Neurological Biomarkers Sale Market Share by Application (2016-2021) 2.5.2 Global Neurological Biomarkers Revenue and Market Share by Application (2016-2021) 2.5.3 Global Neurological Biomarkers Sale Price by Application (2016-2021) 3 Global Neurological Biomarkers by Company 3.1 Global Neurological Biomarkers Sales Market Share by Company 3.1.1 Global Neurological Biomarkers Sales by Company (2019-2021) 3.1.2 Global Neurological Biomarkers Sales Market Share by Company (2019-2021) 3.2 Global Neurological Biomarkers Revenue Market Share by Company 3.2.1 Global Neurological Biomarkers Revenue by Company (2019-2021) 3.2.2 Global Neurological Biomarkers Revenue Market Share by Company (2019-2021) 3.3 Global Neurological Biomarkers Sale Price by Company 3.4 Global Manufacturers Neurological Biomarkers Producing Area Distribution, Sales Area, Product Type 3.4.1 Key Manufacturers Neurological Biomarkers Product Location Distribution 3.4.2 Players Neurological Biomarkers Products Offered 3.5 Market Concentration Rate Analysis 3.5.1 Competition Landscape Analysis 3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2019-2021) 3.6 New Products and Potential Entrants 3.7 Mergers & Acquisitions, Expansion 4 Neurological Biomarkers by Region 4.1 Global Neurological Biomarkers by Region 4.1.1 Global Neurological Biomarkers Sales by Region 4.1.2 Global Neurological Biomarkers Revenue by Region 4.2 Americas Neurological Biomarkers Sales Growth 4.3 APAC Neurological Biomarkers Sales Growth 4.4 Europe Neurological Biomarkers Sales Growth 4.5 Middle East & Africa Neurological Biomarkers Sales Growth 5 Americas 5.1 Americas Neurological Biomarkers Sales by Country 5.1.1 Americas Neurological Biomarkers Sales by Country (2016-2021) 5.1.2 Americas Neurological Biomarkers Revenue by Country (2016-2021) 5.2 Americas Neurological Biomarkers Sales by Type 5.3 Americas Neurological Biomarkers Sales by Application 5.4 United States 5.5 Canada 5.6 Mexico 5.7 Brazil 6 APAC 6.1 APAC Neurological Biomarkers Sales by Region 6.1.1 APAC Neurological Biomarkers Sales by Region (2016-2021) 6.1.2 APAC Neurological Biomarkers Revenue by Region (2016-2021) 6.2 APAC Neurological Biomarkers Sales by Type 6.3 APAC Neurological Biomarkers Sales by Application 6.4 China 6.5 Japan 6.6 Korea 6.7 Southeast Asia 6.8 India 6.9 Australia 7 Europe 7.1 Europe Neurological Biomarkers by Country 7.1.1 Europe Neurological Biomarkers Sales by Country (2016-2021) 7.1.2 Europe Neurological Biomarkers Revenue by Country (2016-2021) 7.2 Europe Neurological Biomarkers Sales by Type 7.3 Europe Neurological Biomarkers Sales by Application 7.4 Germany 7.5 France 7.6 UK 7.7 Italy 7.8 Russia 8 Middle East & Africa 8.1 Middle East & Africa Neurological Biomarkers by Country 8.1.1 Middle East & Africa Neurological Biomarkers Sales by Country (2016-2021) 8.1.2 Middle East & Africa Neurological Biomarkers Revenue by Country (2016-2021) 8.2 Middle East & Africa Neurological Biomarkers Sales by Type 8.3 Middle East & Africa Neurological Biomarkers Sales by Application 8.4 Egypt 8.5 South Africa 8.6 Israel 8.7 Turkey 8.8 GCC Country 9 Market Drivers, Challenges and Trends 9.1 Market Drivers and Impact 9.1.1 Growing Demand from Key Regions 9.1.2 Growing Demand from Key Applications and Potential Industries 9.2 Market Challenges and Impact 9.3 Market Trends 10 Marketing, Distributors and Customer 10.1 Sales Channel 10.1.1 Direct Channels 10.1.2 Indirect Channels 10.2 Neurological Biomarkers Distributors 10.3 Neurological Biomarkers Customer 11 Global Neurological Biomarkers Market Forecast 11.1 Global Neurological Biomarkers Forecast by Region 11.1.1 Global Neurological Biomarkers Forecast by Regions (2021-2026) 11.2.2 Global Neurological Biomarkers Revenue Forecast by Regions (2021-2026) 11.2 Americas Forecast by Country 11.3 APAC Forecast by Region 11.4 Europe Forecast by Country 11.5 Middle East & Africa Forecast by Country 11.6 Global Neurological Biomarkers Forecast by Type 11.7 Global Neurological Biomarkers Forecast by Application 12 Key Players Analysis 12.1 Thermo Fisher Scientific 12.1.1 Thermo Fisher Scientific Company Information 12.1.2 Thermo Fisher Scientific Neurological Biomarkers Product Offered 12.1.3 Thermo Fisher Scientific Neurological Biomarkers Sales, Revenue, Price and Gross Margin (2019-2021) 12.1.4 Thermo Fisher Scientific Main Business Overview 12.1.5 Thermo Fisher Scientific Latest Developments 12.2 Merck 12.2.1 Merck Company Information 12.2.2 Merck Neurological Biomarkers Product Offered 12.2.3 Merck Neurological Biomarkers Sales, Revenue, Price and Gross Margin (2019-2021) 12.2.4 Merck Main Business Overview 12.2.5 Merck Latest Developments 12.3 Quest Diagnostics 12.3.1 Quest Diagnostics Company Information 12.3.2 Quest Diagnostics Neurological Biomarkers Product Offered 12.3.3 Quest Diagnostics Neurological Biomarkers Sales, Revenue, Price and Gross Margin (2019-2021) 12.3.4 Quest Diagnostics Main Business Overview 12.3.5 Quest Diagnostics Latest Developments 12.4 Abbott 12.4.1 Abbott Company Information 12.4.2 Abbott Neurological Biomarkers Product Offered 12.4.3 Abbott Neurological Biomarkers Sales, Revenue, Price and Gross Margin (2019-2021) 12.4.4 Abbott Main Business Overview 12.4.5 Abbott Latest Developments 12.5 Roche 12.5.1 Roche Company Information 12.5.2 Roche Neurological Biomarkers Product Offered 12.5.3 Roche Neurological Biomarkers Sales, Revenue, Price and Gross Margin (2019-2021) 12.5.4 Roche Main Business Overview 12.5.5 Roche Latest Developments 12.6 Illumina 12.6.1 Illumina Company Information 12.6.2 Illumina Neurological Biomarkers Product Offered 12.6.3 Illumina Neurological Biomarkers Sales, Revenue, Price and Gross Margin (2019-2021) 12.6.4 Illumina Main Business Overview 12.6.5 Illumina Latest Developments 12.7 Bio-Rad Laboratories 12.7.1 Bio-Rad Laboratories Company Information 12.7.2 Bio-Rad Laboratories Neurological Biomarkers Product Offered 12.7.3 Bio-Rad Laboratories Neurological Biomarkers Sales, Revenue, Price and Gross Margin (2019-2021) 12.7.4 Bio-Rad Laboratories Main Business Overview 12.7.5 Bio-Rad Laboratories Latest Developments 12.8 QIAGEN 12.8.1 QIAGEN Company Information 12.8.2 QIAGEN Neurological Biomarkers Product Offered 12.8.3 QIAGEN Neurological Biomarkers Sales, Revenue, Price and Gross Margin (2019-2021) 12.8.4 QIAGEN Main Business Overview 12.8.5 QIAGEN Latest Developments 12.9 Myriad RBM 12.9.1 Myriad RBM Company Information 12.9.2 Myriad RBM Neurological Biomarkers Product Offered 12.9.3 Myriad RBM Neurological Biomarkers Sales, Revenue, Price and Gross Margin (2019-2021) 12.9.4 Myriad RBM Main Business Overview 12.9.5 Myriad RBM Latest Developments 12.10 Cisbio Bioassays 12.10.1 Cisbio Bioassays Company Information 12.10.2 Cisbio Bioassays Neurological Biomarkers Product Offered 12.10.3 Cisbio Bioassays Neurological Biomarkers Sales, Revenue, Price and Gross Margin (2019-2021) 12.10.4 Cisbio Bioassays Main Business Overview 12.10.5 Cisbio Bioassays Latest Developments 12.11 Athena Diagnostics 12.11.1 Athena Diagnostics Company Information 12.11.2 Athena Diagnostics Neurological Biomarkers Product Offered 12.11.3 Athena Diagnostics Neurological Biomarkers Sales, Revenue, Price and Gross Margin (2019-2021) 12.11.4 Athena Diagnostics Main Business Overview 12.11.5 Athena Diagnostics Latest Developments 12.12 BGI 12.12.1 BGI Company Information 12.12.2 BGI Neurological Biomarkers Product Offered 12.12.3 BGI Neurological Biomarkers Sales, Revenue, Price and Gross Margin (2019-2021) 12.12.4 BGI Main Business Overview 12.12.5 BGI Latest Developments 12.13 Wuxi APP 12.13.1 Wuxi APP Company Information 12.13.2 Wuxi APP Neurological Biomarkers Product Offered 12.13.3 Wuxi APP Neurological Biomarkers Sales, Revenue, Price and Gross Margin (2019-2021) 12.13.4 Wuxi APP Main Business Overview 12.13.5 Wuxi APP Latest Developments 12.14 Aepodia 12.14.1 Aepodia Company Information 12.14.2 Aepodia Neurological Biomarkers Product Offered 12.14.3 Aepodia Neurological Biomarkers Sales, Revenue, Price and Gross Margin (2019-2021) 12.14.4 Aepodia Main Business Overview 12.14.5 Aepodia Latest Developments 12.15 Proteome Sciences 12.15.1 Proteome Sciences Company Information 12.15.2 Proteome Sciences Neurological Biomarkers Product Offered 12.15.3 Proteome Sciences Neurological Biomarkers Sales, Revenue, Price and Gross Margin (2019-2021) 12.15.4 Proteome Sciences Main Business Overview 12.15.5 Proteome Sciences Latest Developments 12.16 Genewiz 12.16.1 Genewiz Company Information 12.16.2 Genewiz Neurological Biomarkers Product Offered 12.16.3 Genewiz Neurological Biomarkers Sales, Revenue, Price and Gross Margin (2019-2021) 12.16.4 Genewiz Main Business Overview 12.16.5 Genewiz Latest Developments 13 Research Findings and Conclusion

List of Tables Table 1. Neurological Biomarkers Consumption CAGR by Region (2020-2026) & ($ Millions) Table 2. Major Players of Proteomics Table 3. Major Players of Genomics Table 4. Major Players of Imaging Table 5. Major Players of Bioinformatics Table 6. Major Players of Others Table 7. Global Neurological Biomarkers Sales by Type (2016-2021) & (K Units) Table 8. Global Neurological Biomarkers Sales Market Share by Type (2016-2021) Table 9. Global Neurological Biomarkers Revenue by Type (2016-2021) & ($ million) Table 10. Global Neurological Biomarkers Revenue Market Share by Type (2016-2021) Table 11. Global Neurological Biomarkers Sale Price by Type (2016-2021) Table 12. Global Neurological Biomarkers Sales by Application (2016-2021) & (K Units) Table 13. Global Neurological Biomarkers Sales Market Share by Application (2016-2021) Table 14. Global Neurological Biomarkers Value by Application (2016-2021) Table 15. Global Neurological Biomarkers Revenue Market Share by Application (2016-2021) Table 16. Global Neurological Biomarkers Sale Price by Application (2016-2021) Table 17. Global Neurological Biomarkers Sales by Company (2019-2021) & (K Units) Table 18. Global Neurological Biomarkers Sales Market Share by Company (2019-2021) Table 19. Global Neurological Biomarkers Revenue by Company (2019-2021) ($ Millions) Table 20. Global Neurological Biomarkers Revenue Market Share by Company (2019-2021) Table 21. Global Neurological Biomarkers Sale Price by Company (2019-2021) Table 22. Key Manufacturers Neurological Biomarkers Producing Area Distribution and Sales Area Table 23. Players Neurological Biomarkers Products Offered Table 24. Neurological Biomarkers Concentration Ratio (CR3, CR5 and CR10) & (2019-2021) Table 25. New Products and Potential Entrants Table 26. Mergers & Acquisitions, Expansion Table 27. Global Neurological Biomarkers Sales by Region (2016-2021) (K Units) Table 28. Global Neurological Biomarkers Sales Market Share by Region (2016-2021) Table 29. Global Neurological Biomarkers Revenue by Region (2016-2021) & ($ Millions) Table 30. Global Neurological Biomarkers Revenue Market Share by Region (2016-2021) Table 31. Americas Neurological Biomarkers Sales by Country (2016-2021) & (K Units) Table 32. Americas Neurological Biomarkers Sales Market Share by Country (2016-2021) Table 33. Americas Neurological Biomarkers Revenue by Country (2016-2021) & ($ Millions) Table 34. Americas Neurological Biomarkers Revenue Market Share by Country (2016-2021) Table 35. Americas Neurological Biomarkers Sales by Type (2016-2021) & (K Units) Table 36. Americas Neurological Biomarkers Sales Market Share by Type (2016-2021) Table 37. Americas Neurological Biomarkers Sales by Application (2016-2021) & (K Units) Table 38. Americas Neurological Biomarkers Sales Market Share by Application (2016-2021) Table 39. APAC Neurological Biomarkers Sales by Region (2016-2021) & (K Units) Table 40. APAC Neurological Biomarkers Sales Market Share by Region (2016-2021) Table 41. APAC Neurological Biomarkers Revenue by Region (2016-2021) & ($ Millions) Table 42. APAC Neurological Biomarkers Revenue Market Share by Region (2016-2021) Table 43. APAC Neurological Biomarkers Sales by Type (2016-2021) & (K Units) Table 44. APAC Neurological Biomarkers Sales Market Share by Type (2016-2021) Table 45. APAC Neurological Biomarkers Sales by Application (2016-2021) & (K Units) Table 46. APAC Neurological Biomarkers Sales Market Share by Application (2016-2021) Table 47. Europe Neurological Biomarkers Sales by Country (2016-2021) & (K Units) Table 48. Europe Neurological Biomarkers Sales Market Share by Country (2016-2021) Table 49. Europe Neurological Biomarkers Revenue by Country (2016-2021) & ($ Millions) Table 50. Europe Neurological Biomarkers Revenue Market Share by Country (2016-2021) Table 51. Europe Neurological Biomarkers Sales by Type (2016-2021) & (K Units) Table 52. Europe Neurological Biomarkers Sales Market Share by Type (2016-2021) Table 53. Europe Neurological Biomarkers Sales by Application (2016-2021) & (K Units) Table 54. Europe Neurological Biomarkers Sales Market Share by Application (2016-2021) Table 55. Middle East & Africa Neurological Biomarkers Sales by Country (2016-2021) & (K Units) Table 56. Middle East & Africa Neurological Biomarkers Sales Market Share by Country (2016-2021) Table 57. Middle East & Africa Neurological Biomarkers Revenue by Country (2016-2021) & ($ Millions) Table 58. Middle East & Africa Neurological Biomarkers Revenue Market Share by Country (2016-2021) Table 59. Middle East & Africa Neurological Biomarkers Sales by Type (2016-2021) & (K Units) Table 60. Middle East & Africa Neurological Biomarkers Sales Market Share by Type (2016-2021) Table 61. Middle East & Africa Neurological Biomarkers Sales by Application (2016-2021) & (K Units) Table 62. Middle East & Africa Neurological Biomarkers Sales Market Share by Application (2016-2021) Table 63. Key and Potential Regions of Neurological Biomarkers Table 64. Key Application and Potential Industries of Neurological Biomarkers Table 65. Key Challenges of Neurological Biomarkers Table 66. Key Trends of Neurological Biomarkers Table 67. Neurological Biomarkers Distributors List Table 68. Neurological Biomarkers Customer List Table 69. Global Neurological Biomarkers Sales Forecast by Region (2021-2026) & (K Units) Table 70. Global Neurological Biomarkers Consumption Market Forecast by Region Table 71. Global Neurological Biomarkers Revenue Forecast by Region (2021-2026) & ($ millions) Table 72. Global Neurological Biomarkers Revenue Market Share Forecast by Region (2021-2026) Table 73. Americas Neurological Biomarkers Sales Forecast by Country (2021-2026) & (K Units) Table 74. Americas Neurological Biomarkers Revenue Forecast by Country (2021-2026) & ($ millions) Table 75. APAC Neurological Biomarkers Sales Forecast by Region (2021-2026) & (K Units) Table 76. APAC Neurological Biomarkers Revenue Forecast by Region (2021-2026) & ($ millions) Table 77. Europe Neurological Biomarkers Sales Forecast by Country (2021-2026) & (K Units) Table 78. Europe Neurological Biomarkers Revenue Forecast by Country (2021-2026) & ($ millions) Table 79. Middle East & Africa Neurological Biomarkers Sales Forecast by Country (2021-2026) & (K Units) Table 80. Middle East & Africa Neurological Biomarkers Revenue Forecast by Country (2021-2026) & ($ millions) Table 81. Global Neurological Biomarkers Sales Forecast by Type (2021-2026) & (K Units) Table 82. Global Neurological Biomarkers Sales Market Share Forecast by Type (2021-2026) Table 83. Global Neurological Biomarkers Revenue Forecast by Type (2021-2026) & ($ Millions) Table 84. Global Neurological Biomarkers Revenue Market Share Forecast by Type (2021-2026) Table 85. Global Neurological Biomarkers Sales Forecast by Application (2021-2026) & (K Units) Table 86. Global Neurological Biomarkers Sales Market Share Forecast by Application (2021-2026) Table 87. Global Neurological Biomarkers Revenue Forecast by Application (2021-2026) & ($ Millions) Table 88. Global Neurological Biomarkers Revenue Market Share Forecast by Application (2021-2026) Table 89. Thermo Fisher Scientific Basic Information, Neurological Biomarkers Manufacturing Base, Sales Area and Its Competitors Table 90. Thermo Fisher Scientific Neurological Biomarkers Product Offered Table 91. Thermo Fisher Scientific Neurological Biomarkers Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2019-2021E) Table 92. Thermo Fisher Scientific Main Business Table 93. Thermo Fisher Scientific Latest Developments Table 94. Merck Basic Information, Neurological Biomarkers Manufacturing Base, Sales Area and Its Competitors Table 95. Merck Neurological Biomarkers Product Offered Table 96. Merck Neurological Biomarkers Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2019-2021E) Table 97. Merck Main Business Table 98. Merck Latest Developments Table 99. Quest Diagnostics Basic Information, Neurological Biomarkers Manufacturing Base, Sales Area and Its Competitors Table 100. Quest Diagnostics Neurological Biomarkers Product Offered Table 101. Quest Diagnostics Neurological Biomarkers Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2019-2021E) Table 102. Quest Diagnostics Main Business Table 103. Quest Diagnostics Latest Developments Table 104. Abbott Basic Information, Neurological Biomarkers Manufacturing Base, Sales Area and Its Competitors Table 105. Abbott Neurological Biomarkers Product Offered Table 106. Abbott Neurological Biomarkers Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2019-2021E) Table 107. Abbott Main Business Table 108. Abbott Latest Developments Table 109. Roche Basic Information, Neurological Biomarkers Manufacturing Base, Sales Area and Its Competitors Table 110. Roche Neurological Biomarkers Product Offered Table 111. Roche Neurological Biomarkers Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2019-2021E) Table 112. Roche Main Business Table 113. Roche Latest Developments Table 114. Illumina Basic Information, Neurological Biomarkers Manufacturing Base, Sales Area and Its Competitors Table 115. Illumina Neurological Biomarkers Product Offered Table 116. Illumina Neurological Biomarkers Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2019-2021E) Table 117. Illumina Main Business Table 118. Illumina Latest Developments Table 119. Bio-Rad Laboratories Basic Information, Neurological Biomarkers Manufacturing Base, Sales Area and Its Competitors Table 120. Bio-Rad Laboratories Neurological Biomarkers Product Offered Table 121. Bio-Rad Laboratories Neurological Biomarkers Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2019-2021E) Table 122. Bio-Rad Laboratories Main Business Table 123. Bio-Rad Laboratories Latest Developments Table 124. QIAGEN Basic Information, Neurological Biomarkers Manufacturing Base, Sales Area and Its Competitors Table 125. QIAGEN Neurological Biomarkers Product Offered Table 126. QIAGEN Neurological Biomarkers Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2019-2021E) Table 127. QIAGEN Main Business Table 128. QIAGEN Latest Developments Table 129. Myriad RBM Basic Information, Neurological Biomarkers Manufacturing Base, Sales Area and Its Competitors Table 130. Myriad RBM Neurological Biomarkers Product Offered Table 131. Myriad RBM Neurological Biomarkers Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2019-2021E) Table 132. Myriad RBM Main Business Table 133. Myriad RBM Latest Developments Table 134. Cisbio Bioassays Basic Information, Neurological Biomarkers Manufacturing Base, Sales Area and Its Competitors Table 135. Cisbio Bioassays Neurological Biomarkers Product Offered Table 136. Cisbio Bioassays Neurological Biomarkers Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2019-2021E) Table 137. Cisbio Bioassays Main Business Table 138. Cisbio Bioassays Latest Developments Table 139. Athena Diagnostics Basic Information, Neurological Biomarkers Manufacturing Base, Sales Area and Its Competitors Table 140. Athena Diagnostics Neurological Biomarkers Product Offered Table 141. Athena Diagnostics Neurological Biomarkers Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2019-2021E) Table 142. Athena Diagnostics Main Business Table 143. Athena Diagnostics Latest Developments Table 144. BGI Basic Information, Neurological Biomarkers Manufacturing Base, Sales Area and Its Competitors Table 145. BGI Neurological Biomarkers Product Offered Table 146. BGI Neurological Biomarkers Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2019-2021E) Table 147. BGI Main Business Table 148. BGI Latest Developments Table 149. Wuxi APP Basic Information, Neurological Biomarkers Manufacturing Base, Sales Area and Its Competitors Table 150. Wuxi APP Neurological Biomarkers Product Offered Table 151. Wuxi APP Neurological Biomarkers Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2019-2021E) Table 152. Wuxi APP Main Business Table 153. Wuxi APP Latest Developments Table 154. Aepodia Basic Information, Neurological Biomarkers Manufacturing Base, Sales Area and Its Competitors Table 155. Aepodia Neurological Biomarkers Product Offered Table 156. Aepodia Neurological Biomarkers Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2019-2021E) Table 157. Aepodia Main Business Table 158. Aepodia Latest Developments Table 159. Proteome Sciences Basic Information, Neurological Biomarkers Manufacturing Base, Sales Area and Its Competitors Table 160. Proteome Sciences Neurological Biomarkers Product Offered Table 161. Proteome Sciences Neurological Biomarkers Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2019-2021E) Table 162. Proteome Sciences Main Business Table 163. Proteome Sciences Latest Developments Table 164. Genewiz Basic Information, Neurological Biomarkers Manufacturing Base, Sales Area and Its Competitors Table 165. Genewiz Neurological Biomarkers Product Offered Table 166. Genewiz Neurological Biomarkers Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2019-2021E) Table 167. Genewiz Main Business Table 168. Genewiz Latest Developments List of Figures Figure 1. Picture of Neurological Biomarkers Figure 2. Neurological Biomarkers Report Years Considered Figure 3. Research Objectives Figure 4. Research Methodology Figure 5. Research Process and Data Source Figure 6. Global Neurological Biomarkers Sales Growth Rate 2016-2026 (K Units) Figure 7. Global Neurological Biomarkers Revenue Growth Rate 2016-2026 ($ Millions) Figure 8. Neurological Biomarkers Sales by Region (2021 & 2026) & ($ millions) Figure 9. Product Picture of Proteomics Figure 10. Product Picture of Genomics Figure 11. Product Picture of Imaging Figure 12. Product Picture of Bioinformatics Figure 13. Product Picture of Others Figure 14. Global Neurological Biomarkers Sales Market Share by Type in 2020 Figure 15. Global Neurological Biomarkers Revenue Market Share by Type (2016-2021) Figure 16. Neurological Biomarkers Consumed in Diagnostics Figure 17. Global Neurological Biomarkers Market: Diagnostics (2016-2021) & (K Units) Figure 18. Neurological Biomarkers Consumed in Drug Discovery Figure 19. Global Neurological Biomarkers Market: Drug Discovery (2016-2021) & (K Units) Figure 20. Neurological Biomarkers Consumed in Personalized Medicine Figure 21. Global Neurological Biomarkers Market: Personalized Medicine (2016-2021) & (K Units) Figure 22. Neurological Biomarkers Consumed in Others Figure 23. Global Neurological Biomarkers Market: Others (2016-2021) & (K Units) Figure 24. Global Neurological Biomarkers Sales Market Share by Application (2016-2021) Figure 25. Global Neurological Biomarkers Revenue Market Share by Application in 2020 Figure 26. Neurological Biomarkers Revenue Market by Company in 2020 ($ Million) Figure 27. Global Neurological Biomarkers Revenue Market Share by Company in 2020 Figure 28. Global Neurological Biomarkers Sales Market Share by Regions (2016-2021) Figure 29. Global Neurological Biomarkers Revenue Market Share by Region in 2020 Figure 30. Americas Neurological Biomarkers Sales 2016-2021 (K Units) Figure 31. Americas Neurological Biomarkers Revenue 2016-2021 ($ Millions) Figure 32. APAC Neurological Biomarkers Sales 2016-2021 (K Units) Figure 33. APAC Neurological Biomarkers Revenue 2016-2021 ($ Millions) Figure 34. Europe Neurological Biomarkers Sales 2016-2021 (K Units) Figure 35. Europe Neurological Biomarkers Revenue 2016-2021 ($ Millions) Figure 36. Middle East & Africa Neurological Biomarkers Sales 2016-2021 (K Units) Figure 37. Middle East & Africa Neurological Biomarkers Revenue 2016-2021 ($ Millions) Figure 38. Americas Neurological Biomarkers Sales Market Share by Country in 2020 Figure 39. Americas Neurological Biomarkers Revenue Market Share by Country in 2020 Figure 40. Americas Neurological Biomarkers Sales Market Share by Type in 2020 Figure 41. Americas Neurological Biomarkers Sales Market Share by Application in 2020 Figure 42. United States Neurological Biomarkers Revenue Growth 2016-2021 ($ Millions) Figure 43. Canada Neurological Biomarkers Revenue Growth 2016-2021 ($ Millions) Figure 44. Mexico Neurological Biomarkers Revenue Growth 2016-2021 ($ Millions) Figure 45. Brazil Neurological Biomarkers Revenue Growth 2016-2021 ($ Millions) Figure 46. APAC Neurological Biomarkers Sales Market Share by Region in 2020 Figure 47. APAC Neurological Biomarkers Revenue Market Share by Regions in 2020 Figure 48. APAC Neurological Biomarkers Sales Market Share by Type in 2020 Figure 49. APAC Neurological Biomarkers Sales Market Share by Application in 2020 Figure 50. China Neurological Biomarkers Revenue Growth 2016-2021 ($ Millions) Figure 51. Japan Neurological Biomarkers Revenue Growth 2016-2021 ($ Millions) Figure 52. Korea Neurological Biomarkers Revenue Growth 2016-2021 ($ Millions) Figure 53. Southeast Asia Neurological Biomarkers Revenue Growth 2016-2021 ($ Millions) Figure 54. India Neurological Biomarkers Revenue Growth 2016-2021 ($ Millions) Figure 55. Australia Neurological Biomarkers Revenue Growth 2016-2021 ($ Millions) Figure 56. Europe Neurological Biomarkers Sales Market Share by Country in 2020 Figure 57. Europe Neurological Biomarkers Revenue Market Share by Country in 2020 Figure 58. Europe Neurological Biomarkers Sales Market Share by Type in 2020 Figure 59. Europe Neurological Biomarkers Sales Market Share by Application in 2020 Figure 60. Germany Neurological Biomarkers Revenue Growth 2016-2021 ($ Millions) Figure 61. France Neurological Biomarkers Revenue Growth 2016-2021 ($ Millions) Figure 62. UK Neurological Biomarkers Revenue Growth 2016-2021 ($ Millions) Figure 63. Italy Neurological Biomarkers Revenue Growth 2016-2021 ($ Millions) Figure 64. Russia Neurological Biomarkers Revenue Growth 2016-2021 ($ Millions) Figure 65. Middle East & Africa Neurological Biomarkers Sales Market Share by Country in 2020 Figure 66. Middle East & Africa Neurological Biomarkers Revenue Market Share by Country in 2020 Figure 67. Middle East & Africa Neurological Biomarkers Sales Market Share by Type in 2020 Figure 68. Middle East & Africa Neurological Biomarkers Sales Market Share by Application in 2020 Figure 69. Egypt Neurological Biomarkers Revenue Growth 2016-2021 ($ Millions) Figure 70. South Africa Neurological Biomarkers Revenue Growth 2016-2021 ($ Millions) Figure 71. Israel Neurological Biomarkers Revenue Growth 2016-2021 ($ Millions) Figure 72. Turkey Neurological Biomarkers Revenue Growth 2016-2021 ($ Millions) Figure 73. GCC Country Neurological Biomarkers Revenue Growth 2016-2021 ($ Millions) Figure 74. Channels of Distribution Figure 75. Distributors Profiles